<b>NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties</b>.

Huang, Peng; Ho, Conrad K; Cao, Danni; Inan, Saadet; Rawls, Scott M; Li, Mengchu; Huang, Boshi; Pagare, Piyusha P; Townsend, E Andrew; Poklis, Justin L; Halquist, Matthew S; Banks, Matthew; Zhang, Yan; Liu-Chen, Lee-Yuan

NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties.

Huang, Peng; Ho, Conrad K; Cao, Danni; Inan, Saadet; Rawls, Scott M; Li, Mengchu; Huang, Boshi; Pagare, Piyusha P; Townsend, E Andrew; Poklis, Justin L; Halquist, Matthew S; Banks, Matthew; Zhang, Yan; Liu-Chen, Lee-Yuan.

Afiliação

Huang P; Temple University Lewis Katz School of Medicine, United States.
Ho CK; Temple University Lewis Katz School of Medicine, United States.
Cao D; Temple University Lewis Katz School of Medicine, United States.
Inan S; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Lewis Katz School of Medicine, Temple University, United States.
Rawls SM; Temple University Lewis Katz School of Medicine, United States.
Li M; Virginia Commonwealth University School of Pharmacy, United States.
Huang B; Virginia Commonwealth University School of Pharmacy, United States.
Pagare PP; Virginia Commonwealth University School of Pharmacy, United States.
Townsend EA; Virginia Commonwealth University School of Medicine, United States.
Poklis JL; Virginia Commonwealth University, United States.
Halquist MS; Pharmaceutics, Virginia Commonwealth University, United States.
Banks M; Virginia Commonwealth University School of Medicine, United States.
Zhang Y; Virginia Commonwealth University School of Pharmacy, United States.
Liu-Chen LY; Center for Substance Abuse Research, Temple University Lewis Katz School of Medicine, United States lliuche@temple.edu.